Status:
UNKNOWN
Impact of Rotavirus Vaccine Introduction for South Australian Children
Lead Sponsor:
Associate Professor Helen Marshall
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Viral Gastroenteritis Due to Rotavirus
Gastroenteritis
Eligibility:
All Genders
Up to 6 years
Brief Summary
This project aims to assess the impact of rotavirus vaccine introduction on severe gastroenteritis in South Australian children. Prevalence of rotavirus coded hospitalisations and all-cause gastroente...
Detailed Description
This project aims to assess vaccine effectiveness in the field following introduction of the rotavirus vaccine in South Australian children. It is important to confirm the benefits of the vaccine post...
Eligibility Criteria
Inclusion
- males and females aged 0-less than 6 years of age admitted to SA hospital with ICD10-AM separation codes consistent with rotaviral infection or gastroenteritis of any cause.
- for severity component, only admissions to the Women's and Children's Hospital will be examined
Exclusion
- nosocomial rotaviral infections (defined as onset \>48 hours post admission date) will be reported separately in the severity analysis
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT01472575
Start Date
May 1 2009
End Date
December 1 2011
Last Update
November 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's and Children's Hospital
North Adelaide, South Australia, Australia, 5006